Pipenzolate: Difference between revisions
Created page with "{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 404679302 | IUPAC_name = 1-ethyl-3-(2-hydroxy-2,2-diphenylacetoxy)-1-methylpiperidinium | imag..." |
m Protected "Pipenzolate": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
||
(One intermediate revision by one other user not shown) | |||
Line 52: | Line 52: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Pipenzolate''' is an [[antimuscarinic]]. It binds to muscarinic receptors as an antagonist therefore preventing acetyl choline from binding to the receptors. | '''Pipenzolate''' is an [[antimuscarinic]]. It binds to muscarinic receptors as an antagonist therefore preventing acetyl choline from binding to the receptors. |
Latest revision as of 16:57, 20 August 2015
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H28NO3 |
Molar mass | 354.46 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Pipenzolate |
Articles |
---|
Most recent articles on Pipenzolate Most cited articles on Pipenzolate |
Media |
Powerpoint slides on Pipenzolate |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Pipenzolate at Clinical Trials.gov Clinical Trials on Pipenzolate at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Pipenzolate
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Pipenzolate Discussion groups on Pipenzolate Patient Handouts on Pipenzolate Directions to Hospitals Treating Pipenzolate Risk calculators and risk factors for Pipenzolate
|
Healthcare Provider Resources |
Causes & Risk Factors for Pipenzolate |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pipenzolate is an antimuscarinic. It binds to muscarinic receptors as an antagonist therefore preventing acetyl choline from binding to the receptors.
References
- Pages with script errors
- Articles with changed ChemSpider identifier
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles with changed InChI identifier
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Muscarinic antagonists
- Quaternary ammonium compounds
- Piperidines
- Alcohols
- Drug